Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?

Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?

Tuesday, May 7, 2024 7:50 PM to 7:55 PM · 5 min. (Africa/Abidjan)
Conference Theater 2
Track-Start-Up
Zerion PharmaZerion Pharma A/S is a pharmaceutical development company improving the formulation of poorly soluble drugs (oral solid dosage forms) that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, Dispersome(R)️, we aim to develop new treatment options for patients across all therapeutic areas.

Registered attendees

Ben Murray
Ben Murray
Commercial ManagerArclin
Carlos Bendicho
Carlos Bendicho
DoctorFABRX LIMITED
Danielle Hotten
Danielle Hotten
Director, BDPorton USA

Log in

See all the content and easy-to-use features by logging in or registering!